Geno J Germano insider trades
Open-market stock purchases and sales by Geno J Germano, Director at Precision Biosciences Inc, from SEC Form 4 filings since Feb 24, 2011.
Track record: 67% of 6 scored buys are up 5% or more since purchase, averaging +46%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | DTIL Precision Biosciences Inc | Bought (not open market) | — |
| May 20, 2026 | DTIL Precision Biosciences Inc | Bought (not open market) | — |
| May 14, 2026 | HRMY Harmony Biosciences Holdings, Inc | Bought (not open market) | — |
| Mar 9, 2026 | ENTX Entera Bio Ltd | Bought | $26K |
| Feb 10, 2026 | ENTX Entera Bio Ltd | Bought | $29.8K |
| Dec 16, 2025 | DTIL Precision Biosciences Inc | Bought | $14.2K |
Companies traded
- DTIL Precision Biosciences Inc: 3 buys, last Jun 3, 2026
- HRMY Harmony Biosciences Holdings, Inc: other filings, last May 14, 2026
- ENTX Entera Bio Ltd: 2 buys, last Mar 9, 2026
- SAGE Sage Therapeutics, Inc: other filings, last Jul 31, 2025
- MDCO Medicines Co /DE: other filings, last Jan 6, 2020
- BIVV Bioverativ Inc: other filings, last Mar 8, 2018
- XON Intrexon Corp: other filings, last Sep 22, 2016
- PFE Pfizer Inc: 2 sales, last Feb 26, 2015
- ZTS Zoetis Inc: 1 buy, last Feb 6, 2013